CONATUS PHARMACEUTICALS INC's ticker is CNAT and the CUSIP is 20600T108. A total of 74 filers reported holding CONATUS PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 0.59 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $13,000 | -18.8% | 43,940 | +5.9% | 0.01% | 0.0% |
| Q4 2019 | $16,000 | +14.3% | 41,500 | -12.6% | 0.01% | 0.0% |
| Q3 2019 | $14,000 | +16.7% | 47,500 | 0.0% | 0.01% | +20.0% |
| Q2 2019 | $12,000 | -87.6% | 47,500 | -6.8% | 0.01% | -89.4% |
| Q4 2018 | $97,000 | -62.8% | 50,940 | +9.0% | 0.05% | -66.4% |
| Q3 2018 | $261,000 | +218.3% | 46,750 | +211.7% | 0.14% | +278.4% |
| Q2 2018 | $82,000 | -50.0% | 15,000 | -50.0% | 0.04% | -22.9% |
| Q1 2018 | $164,000 | – | 30,000 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|